OneBreath™ utilizes a proprietary silicon microchip that captures specific Volatile Organic Compounds (VOCs) from a single exhaled breath sample which can be quantitatively analyzed by conventionally available mass spectrometers. The OneBreath™ test can deliver definitive results within 24 hours of sample collection using the safest method for lung cancer detection/diagnosis to date.

The OneBreath™ test can be done in office-based, and retail (pharmacy/drugstores) settings, enabling greater accessibility to lung cancer screening and diagnosis for the general population, which will enhance the potential for early detection.